 | • レポートコード：MRC2-11QY03059 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はベラプロストのグローバル市場について調査・分析したレポートです。種類別（20 Ugタブレット、40Ugタブレット）市場規模、用途別（脊柱管、慢性腎不全、糸球体線維症、末梢血管疾患、慢性動脈閉塞性疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ベラプロストの競争状況、市場シェア ・世界のベラプロスト市場：種類別市場規模 2015年-2020年（20 Ugタブレット、40Ugタブレット） ・世界のベラプロスト市場：種類別市場規模予測 2021年-2026年（20 Ugタブレット、40Ugタブレット） ・世界のベラプロスト市場：用途別市場規模 2015年-2020年（脊柱管、慢性腎不全、糸球体線維症、末梢血管疾患、慢性動脈閉塞性疾患、その他） ・世界のベラプロスト市場：用途別市場規模予測 2021年-2026年（脊柱管、慢性腎不全、糸球体線維症、末梢血管疾患、慢性動脈閉塞性疾患、その他） ・北米のベラプロスト市場分析：米国、カナダ ・ヨーロッパのベラプロスト市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのベラプロスト市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のベラプロスト市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのベラプロスト市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Asahi Kasei Pharma、Shin Poong、Shiono Kemikaru、Ohara Yakuhin、Pfizer、Sawai Seiyaku、Teva、Towa Yakuhin、Yoshindo、Toray、Astellas、Kaken Seiyaku、Green Cross、Choseido Pharmaceutical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Beraprost Market
The global Beraprost market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Beraprost Scope and Market Size
Beraprost market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Beraprost market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Beraprost market is segmented into
20 Ug Tablet
40 Ug Tablet
Segment by Application, the Beraprost market is segmented into
Spinal Canal
Chronic Renal Failure
Glomerular Fibrosis
Peripheral Vascular Disease
Chronic Arterial Occlusive Disease
Other
Regional and Country-level Analysis
The Beraprost market is analysed and market size information is provided by regions (countries).
The key regions covered in the Beraprost market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Beraprost Market Share Analysis
Beraprost market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Beraprost business, the date to enter into the Beraprost market, Beraprost product introduction, recent developments, etc.
The major vendors covered:
Asahi Kasei Pharma
Shin Poong
Shiono Kemikaru
Ohara Yakuhin
Pfizer
Sawai Seiyaku
Teva
Towa Yakuhin
Yoshindo
Toray
Astellas
Kaken Seiyaku
Green Cross
Choseido Pharmaceutical
1 Study Coverage
1.1 Beraprost Product Introduction
1.2 Market Segments
1.3 Key Beraprost Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Beraprost Market Size Growth Rate by Type
1.4.2 20 Ug Tablet
1.4.3 40 Ug Tablet
1.5 Market by Application
1.5.1 Global Beraprost Market Size Growth Rate by Application
1.5.2 Spinal Canal
1.5.3 Chronic Renal Failure
1.5.4 Glomerular Fibrosis
1.5.5 Peripheral Vascular Disease
1.5.6 Chronic Arterial Occlusive Disease
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Beraprost Market Size, Estimates and Forecasts
2.1.1 Global Beraprost Revenue 2015-2026
2.1.2 Global Beraprost Sales 2015-2026
2.2 Global Beraprost, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Beraprost Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Beraprost Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Beraprost Competitor Landscape by Players
3.1 Beraprost Sales by Manufacturers
3.1.1 Beraprost Sales by Manufacturers (2015-2020)
3.1.2 Beraprost Sales Market Share by Manufacturers (2015-2020)
3.2 Beraprost Revenue by Manufacturers
3.2.1 Beraprost Revenue by Manufacturers (2015-2020)
3.2.2 Beraprost Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Beraprost Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Beraprost Revenue in 2019
3.2.5 Global Beraprost Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Beraprost Price by Manufacturers
3.4 Beraprost Manufacturing Base Distribution, Product Types
3.4.1 Beraprost Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Beraprost Product Type
3.4.3 Date of International Manufacturers Enter into Beraprost Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Beraprost Market Size by Type (2015-2020)
4.1.1 Global Beraprost Sales by Type (2015-2020)
4.1.2 Global Beraprost Revenue by Type (2015-2020)
4.1.3 Beraprost Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Beraprost Market Size Forecast by Type (2021-2026)
4.2.1 Global Beraprost Sales Forecast by Type (2021-2026)
4.2.2 Global Beraprost Revenue Forecast by Type (2021-2026)
4.2.3 Beraprost Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Beraprost Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Beraprost Market Size by Application (2015-2020)
5.1.1 Global Beraprost Sales by Application (2015-2020)
5.1.2 Global Beraprost Revenue by Application (2015-2020)
5.1.3 Beraprost Price by Application (2015-2020)
5.2 Beraprost Market Size Forecast by Application (2021-2026)
5.2.1 Global Beraprost Sales Forecast by Application (2021-2026)
5.2.2 Global Beraprost Revenue Forecast by Application (2021-2026)
5.2.3 Global Beraprost Price Forecast by Application (2021-2026)
6 North America
6.1 North America Beraprost by Country
6.1.1 North America Beraprost Sales by Country
6.1.2 North America Beraprost Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Beraprost Market Facts & Figures by Type
6.3 North America Beraprost Market Facts & Figures by Application
7 Europe
7.1 Europe Beraprost by Country
7.1.1 Europe Beraprost Sales by Country
7.1.2 Europe Beraprost Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Beraprost Market Facts & Figures by Type
7.3 Europe Beraprost Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Beraprost by Region
8.1.1 Asia Pacific Beraprost Sales by Region
8.1.2 Asia Pacific Beraprost Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Beraprost Market Facts & Figures by Type
8.3 Asia Pacific Beraprost Market Facts & Figures by Application
9 Latin America
9.1 Latin America Beraprost by Country
9.1.1 Latin America Beraprost Sales by Country
9.1.2 Latin America Beraprost Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Beraprost Market Facts & Figures by Type
9.3 Central & South America Beraprost Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Beraprost by Country
10.1.1 Middle East and Africa Beraprost Sales by Country
10.1.2 Middle East and Africa Beraprost Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Beraprost Market Facts & Figures by Type
10.3 Middle East and Africa Beraprost Market Facts & Figures by Application
11 Company Profiles
11.1 Asahi Kasei Pharma
11.1.1 Asahi Kasei Pharma Corporation Information
11.1.2 Asahi Kasei Pharma Description and Business Overview
11.1.3 Asahi Kasei Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Asahi Kasei Pharma Beraprost Products Offered
11.1.5 Asahi Kasei Pharma Related Developments
11.2 Shin Poong
11.2.1 Shin Poong Corporation Information
11.2.2 Shin Poong Description and Business Overview
11.2.3 Shin Poong Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Shin Poong Beraprost Products Offered
11.2.5 Shin Poong Related Developments
11.3 Shiono Kemikaru
11.3.1 Shiono Kemikaru Corporation Information
11.3.2 Shiono Kemikaru Description and Business Overview
11.3.3 Shiono Kemikaru Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shiono Kemikaru Beraprost Products Offered
11.3.5 Shiono Kemikaru Related Developments
11.4 Ohara Yakuhin
11.4.1 Ohara Yakuhin Corporation Information
11.4.2 Ohara Yakuhin Description and Business Overview
11.4.3 Ohara Yakuhin Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Ohara Yakuhin Beraprost Products Offered
11.4.5 Ohara Yakuhin Related Developments
11.5 Pfizer
11.5.1 Pfizer Corporation Information
11.5.2 Pfizer Description and Business Overview
11.5.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Pfizer Beraprost Products Offered
11.5.5 Pfizer Related Developments
11.6 Sawai Seiyaku
11.6.1 Sawai Seiyaku Corporation Information
11.6.2 Sawai Seiyaku Description and Business Overview
11.6.3 Sawai Seiyaku Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sawai Seiyaku Beraprost Products Offered
11.6.5 Sawai Seiyaku Related Developments
11.7 Teva
11.7.1 Teva Corporation Information
11.7.2 Teva Description and Business Overview
11.7.3 Teva Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Teva Beraprost Products Offered
11.7.5 Teva Related Developments
11.8 Towa Yakuhin
11.8.1 Towa Yakuhin Corporation Information
11.8.2 Towa Yakuhin Description and Business Overview
11.8.3 Towa Yakuhin Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Towa Yakuhin Beraprost Products Offered
11.8.5 Towa Yakuhin Related Developments
11.9 Yoshindo
11.9.1 Yoshindo Corporation Information
11.9.2 Yoshindo Description and Business Overview
11.9.3 Yoshindo Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Yoshindo Beraprost Products Offered
11.9.5 Yoshindo Related Developments
11.10 Toray
11.10.1 Toray Corporation Information
11.10.2 Toray Description and Business Overview
11.10.3 Toray Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Toray Beraprost Products Offered
11.10.5 Toray Related Developments
11.1 Asahi Kasei Pharma
11.1.1 Asahi Kasei Pharma Corporation Information
11.1.2 Asahi Kasei Pharma Description and Business Overview
11.1.3 Asahi Kasei Pharma Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Asahi Kasei Pharma Beraprost Products Offered
11.1.5 Asahi Kasei Pharma Related Developments
11.12 Kaken Seiyaku
11.12.1 Kaken Seiyaku Corporation Information
11.12.2 Kaken Seiyaku Description and Business Overview
11.12.3 Kaken Seiyaku Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Kaken Seiyaku Products Offered
11.12.5 Kaken Seiyaku Related Developments
11.13 Green Cross
11.13.1 Green Cross Corporation Information
11.13.2 Green Cross Description and Business Overview
11.13.3 Green Cross Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Green Cross Products Offered
11.13.5 Green Cross Related Developments
11.14 Choseido Pharmaceutical
11.14.1 Choseido Pharmaceutical Corporation Information
11.14.2 Choseido Pharmaceutical Description and Business Overview
11.14.3 Choseido Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Choseido Pharmaceutical Products Offered
11.14.5 Choseido Pharmaceutical Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Beraprost Market Estimates and Projections by Region
12.1.1 Global Beraprost Sales Forecast by Regions 2021-2026
12.1.2 Global Beraprost Revenue Forecast by Regions 2021-2026
12.2 North America Beraprost Market Size Forecast (2021-2026)
12.2.1 North America: Beraprost Sales Forecast (2021-2026)
12.2.2 North America: Beraprost Revenue Forecast (2021-2026)
12.2.3 North America: Beraprost Market Size Forecast by Country (2021-2026)
12.3 Europe Beraprost Market Size Forecast (2021-2026)
12.3.1 Europe: Beraprost Sales Forecast (2021-2026)
12.3.2 Europe: Beraprost Revenue Forecast (2021-2026)
12.3.3 Europe: Beraprost Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Beraprost Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Beraprost Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Beraprost Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Beraprost Market Size Forecast by Region (2021-2026)
12.5 Latin America Beraprost Market Size Forecast (2021-2026)
12.5.1 Latin America: Beraprost Sales Forecast (2021-2026)
12.5.2 Latin America: Beraprost Revenue Forecast (2021-2026)
12.5.3 Latin America: Beraprost Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Beraprost Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Beraprost Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Beraprost Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Beraprost Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Beraprost Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Beraprost Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Beraprost Market Segments
Table 2. Ranking of Global Top Beraprost Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Beraprost Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of 20 Ug Tablet
Table 5. Major Manufacturers of 40 Ug Tablet
Table 6. Global Beraprost Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Beraprost Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Beraprost Sales by Regions 2015-2020 (K Units)
Table 9. Global Beraprost Sales Market Share by Regions (2015-2020)
Table 10. Global Beraprost Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Beraprost Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Beraprost Sales Share by Manufacturers (2015-2020)
Table 13. Global Beraprost Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Beraprost by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beraprost as of 2019)
Table 15. Beraprost Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Beraprost Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Beraprost Price (2015-2020) (US$/Unit)
Table 18. Beraprost Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Beraprost Product Type
Table 20. Date of International Manufacturers Enter into Beraprost Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Beraprost Sales by Type (2015-2020) (K Units)
Table 23. Global Beraprost Sales Share by Type (2015-2020)
Table 24. Global Beraprost Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Beraprost Revenue Share by Type (2015-2020)
Table 26. Beraprost Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)
Table 27. Global Beraprost Sales by Application (2015-2020) (K Units)
Table 28. Global Beraprost Sales Share by Application (2015-2020)
Table 29. North America Beraprost Sales by Country (2015-2020) (K Units)
Table 30. North America Beraprost Sales Market Share by Country (2015-2020)
Table 31. North America Beraprost Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Beraprost Revenue Market Share by Country (2015-2020)
Table 33. North America Beraprost Sales by Type (2015-2020) (K Units)
Table 34. North America Beraprost Sales Market Share by Type (2015-2020)
Table 35. North America Beraprost Sales by Application (2015-2020) (K Units)
Table 36. North America Beraprost Sales Market Share by Application (2015-2020)
Table 37. Europe Beraprost Sales by Country (2015-2020) (K Units)
Table 38. Europe Beraprost Sales Market Share by Country (2015-2020)
Table 39. Europe Beraprost Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Beraprost Revenue Market Share by Country (2015-2020)
Table 41. Europe Beraprost Sales by Type (2015-2020) (K Units)
Table 42. Europe Beraprost Sales Market Share by Type (2015-2020)
Table 43. Europe Beraprost Sales by Application (2015-2020) (K Units)
Table 44. Europe Beraprost Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Beraprost Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Beraprost Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Beraprost Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Beraprost Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Beraprost Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Beraprost Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Beraprost Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Beraprost Sales Market Share by Application (2015-2020)
Table 53. Latin America Beraprost Sales by Country (2015-2020) (K Units)
Table 54. Latin America Beraprost Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Beraprost Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Beraprost Revenue Market Share by Country (2015-2020)
Table 57. Latin America Beraprost Sales by Type (2015-2020) (K Units)
Table 58. Latin America Beraprost Sales Market Share by Type (2015-2020)
Table 59. Latin America Beraprost Sales by Application (2015-2020) (K Units)
Table 60. Latin America Beraprost Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Beraprost Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Beraprost Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Beraprost Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Beraprost Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Beraprost Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Beraprost Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Beraprost Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Beraprost Sales Market Share by Application (2015-2020)
Table 69. Asahi Kasei Pharma Corporation Information
Table 70. Asahi Kasei Pharma Description and Major Businesses
Table 71. Asahi Kasei Pharma Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 72. Asahi Kasei Pharma Product
Table 73. Asahi Kasei Pharma Recent Development
Table 74. Shin Poong Corporation Information
Table 75. Shin Poong Description and Major Businesses
Table 76. Shin Poong Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 77. Shin Poong Product
Table 78. Shin Poong Recent Development
Table 79. Shiono Kemikaru Corporation Information
Table 80. Shiono Kemikaru Description and Major Businesses
Table 81. Shiono Kemikaru Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 82. Shiono Kemikaru Product
Table 83. Shiono Kemikaru Recent Development
Table 84. Ohara Yakuhin Corporation Information
Table 85. Ohara Yakuhin Description and Major Businesses
Table 86. Ohara Yakuhin Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 87. Ohara Yakuhin Product
Table 88. Ohara Yakuhin Recent Development
Table 89. Pfizer Corporation Information
Table 90. Pfizer Description and Major Businesses
Table 91. Pfizer Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 92. Pfizer Product
Table 93. Pfizer Recent Development
Table 94. Sawai Seiyaku Corporation Information
Table 95. Sawai Seiyaku Description and Major Businesses
Table 96. Sawai Seiyaku Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 97. Sawai Seiyaku Product
Table 98. Sawai Seiyaku Recent Development
Table 99. Teva Corporation Information
Table 100. Teva Description and Major Businesses
Table 101. Teva Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 102. Teva Product
Table 103. Teva Recent Development
Table 104. Towa Yakuhin Corporation Information
Table 105. Towa Yakuhin Description and Major Businesses
Table 106. Towa Yakuhin Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 107. Towa Yakuhin Product
Table 108. Towa Yakuhin Recent Development
Table 109. Yoshindo Corporation Information
Table 110. Yoshindo Description and Major Businesses
Table 111. Yoshindo Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 112. Yoshindo Product
Table 113. Yoshindo Recent Development
Table 114. Toray Corporation Information
Table 115. Toray Description and Major Businesses
Table 116. Toray Beraprost Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 117. Toray Product
Table 118. Toray Recent Development
Table 119. Astellas Corporation Information
Table 120. Astellas Description and Major Businesses
Table 121. Astellas Beraprost Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 122. Astellas Product
Table 123. Astellas Recent Development
Table 124. Kaken Seiyaku Corporation Information
Table 125. Kaken Seiyaku Description and Major Businesses
Table 126. Kaken Seiyaku Beraprost Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 127. Kaken Seiyaku Product
Table 128. Kaken Seiyaku Recent Development
Table 129. Green Cross Corporation Information
Table 130. Green Cross Description and Major Businesses
Table 131. Green Cross Beraprost Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 132. Green Cross Product
Table 133. Green Cross Recent Development
Table 134. Choseido Pharmaceutical Corporation Information
Table 135. Choseido Pharmaceutical Description and Major Businesses
Table 136. Choseido Pharmaceutical Beraprost Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 137. Choseido Pharmaceutical Product
Table 138. Choseido Pharmaceutical Recent Development
Table 139. Global Beraprost Sales Forecast by Regions (2021-2026) (K Units)
Table 140. Global Beraprost Sales Market Share Forecast by Regions (2021-2026)
Table 141. Global Beraprost Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 142. Global Beraprost Revenue Market Share Forecast by Regions (2021-2026)
Table 143. North America: Beraprost Sales Forecast by Country (2021-2026) (K Units)
Table 144. North America: Beraprost Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Europe: Beraprost Sales Forecast by Country (2021-2026) (K Units)
Table 146. Europe: Beraprost Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Asia Pacific: Beraprost Sales Forecast by Region (2021-2026) (K Units)
Table 148. Asia Pacific: Beraprost Revenue Forecast by Region (2021-2026) (US$ Million)
Table 149. Latin America: Beraprost Sales Forecast by Country (2021-2026) (K Units)
Table 150. Latin America: Beraprost Revenue Forecast by Country (2021-2026) (US$ Million)
Table 151. Middle East and Africa: Beraprost Sales Forecast by Country (2021-2026) (K Units)
Table 152. Middle East and Africa: Beraprost Revenue Forecast by Country (2021-2026) (US$ Million)
Table 153. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 154. Key Challenges
Table 155. Market Risks
Table 156. Main Points Interviewed from Key Beraprost Players
Table 157. Beraprost Customers List
Table 158. Beraprost Distributors List
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Beraprost Product Picture
Figure 2. Global Beraprost Sales Market Share by Type in 2020 & 2026
Figure 3. 20 Ug Tablet Product Picture
Figure 4. 40 Ug Tablet Product Picture
Figure 5. Global Beraprost Sales Market Share by Application in 2020 & 2026
Figure 6. Spinal Canal
Figure 7. Chronic Renal Failure
Figure 8. Glomerular Fibrosis
Figure 9. Peripheral Vascular Disease
Figure 10. Chronic Arterial Occlusive Disease
Figure 11. Other
Figure 12. Beraprost Report Years Considered
Figure 13. Global Beraprost Market Size 2015-2026 (US$ Million)
Figure 14. Global Beraprost Sales 2015-2026 (K Units)
Figure 15. Global Beraprost Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Beraprost Sales Market Share by Region (2015-2020)
Figure 17. Global Beraprost Sales Market Share by Region in 2019
Figure 18. Global Beraprost Revenue Market Share by Region (2015-2020)
Figure 19. Global Beraprost Revenue Market Share by Region in 2019
Figure 20. Global Beraprost Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Beraprost Revenue in 2019
Figure 22. Beraprost Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Beraprost Sales Market Share by Type (2015-2020)
Figure 24. Global Beraprost Sales Market Share by Type in 2019
Figure 25. Global Beraprost Revenue Market Share by Type (2015-2020)
Figure 26. Global Beraprost Revenue Market Share by Type in 2019
Figure 27. Global Beraprost Market Share by Price Range (2015-2020)
Figure 28. Global Beraprost Sales Market Share by Application (2015-2020)
Figure 29. Global Beraprost Sales Market Share by Application in 2019
Figure 30. Global Beraprost Revenue Market Share by Application (2015-2020)
Figure 31. Global Beraprost Revenue Market Share by Application in 2019
Figure 32. North America Beraprost Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Beraprost Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Beraprost Sales Market Share by Country in 2019
Figure 35. North America Beraprost Revenue Market Share by Country in 2019
Figure 36. U.S. Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Beraprost Market Share by Type in 2019
Figure 41. North America Beraprost Market Share by Application in 2019
Figure 42. Europe Beraprost Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Beraprost Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Beraprost Sales Market Share by Country in 2019
Figure 45. Europe Beraprost Revenue Market Share by Country in 2019
Figure 46. Germany Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Beraprost Market Share by Type in 2019
Figure 57. Europe Beraprost Market Share by Application in 2019
Figure 58. Asia Pacific Beraprost Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Beraprost Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Beraprost Sales Market Share by Region in 2019
Figure 61. Asia Pacific Beraprost Revenue Market Share by Region in 2019
Figure 62. China Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Beraprost Market Share by Type in 2019
Figure 85. Asia Pacific Beraprost Market Share by Application in 2019
Figure 86. Latin America Beraprost Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Beraprost Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Beraprost Sales Market Share by Country in 2019
Figure 89. Latin America Beraprost Revenue Market Share by Country in 2019
Figure 90. Mexico Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Beraprost Market Share by Type in 2019
Figure 97. Latin America Beraprost Market Share by Application in 2019
Figure 98. Middle East and Africa Beraprost Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Beraprost Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Beraprost Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Beraprost Revenue Market Share by Country in 2019
Figure 102. Turkey Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. UAE Beraprost Sales Growth Rate (2015-2020) (K Units)
Figure 107. UAE Beraprost Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Beraprost Market Share by Type in 2019
Figure 109. Middle East and Africa Beraprost Market Share by Application in 2019
Figure 110. North America Beraprost Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Beraprost Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Beraprost Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Beraprost Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Beraprost Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Beraprost Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Beraprost Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Beraprost Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Beraprost Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Beraprost Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
末梢動脈疾患（PAD）治療薬の世界市場（～2026年） Peripheral artery disease (PAD) is a narrowing of the arteries other than those that supply the heart or the brain. When narrowing occurs in the heart, it is called coronary artery disease, while, in the brain, it is called cerebrovascular disease. Peripheral artery disease most commonly affects the…- 末梢動脈疾患（PAD）薬の世界市場（～2026年） Market Analysis and Insights: Global Peripheral Arterial Disease (PAD) Drugs Market The global Peripheral Arterial Disease (PAD) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Peripheral Arterial Disease (PAD) D…
- 慢性腎臓病（CKD）の世界市場（～2026年） Market Analysis and Insights: Global Chronic Kidney Disease (CKD) Market The global Chronic Kidney Disease (CKD) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Kidney Disease (CKD) Scope and Market Size Chroni…
- 慢性閉塞性肺疾患（COPD）の世界市場（～2026年） Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eve…
- 慢性閉塞性肺疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Chronic Obstructive Pulmonary Disease Treatment Market The global Chronic Obstructive Pulmonary Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Chronic Obstructive…